Eclipsebio Announces a $14 Million Series A Financing to Advance Its RNA Genomics Technology Platform
- Tuesday, March 15, 2022, 7:00
- Finance
- Add a comment
RNA is increasingly the focus of medicine, new therapeutics, and vaccines Eclipsebio leads the field of RNA genomics with a suite of data-driven technologies revealing RNA structure, modifications, interactions, and translation Eclipsebio plans to leverage this capital raise to accelerate…
About the Author
adminasapcorp has written 41828 stories on this site.